Round out your CMHC Live Online educational experience by attending Professional Medical Education/Product Theater symposia focused on novel therapies. These non-certified activities are planned solely by the sponsoring organizations/companies.
Friday, August 7, 2020 · 11:45 AM – 12:45 PM
The Continuum of Heart Failure
Presented by:Pam R. Taub, MD
The objective of this program is to discuss the pathophysiology, disease burden, and management of heart failure (HF). The program will present data on HF prevalence and health outcomes, review the implications of type 2 diabetes as a common comorbidity, and provide guidance on diagnosing HF. It will conclude with a brief overview of current treatment options for HF, as well as treatments currently under investigation.
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc./Lilly USA.
Saturday, August 8, 2020 · 11:50 AM – 12:50 PM
VASCEPA® (icosapent ethyl): Elevating the Standard of Care
Presented by: John G. Canto, MD, MSPH
There is an urgency to treat Persistent Cardiovascular Risk (P-CVR) as it remains high despite statin-based standard-of-care therapy in patients with elevated triglycerides. In this program, we will review data from a practice changing trial that provides a groundbreaking therapeutic option to elevate the current standard of care.
Sponsored by Amarin Pharma, Inc.